RNU7-38P

Across TCGA pan-cancer cohorts, RNU7-38P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated RNU7-38P data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher RNU7-38P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU7-38P expression acts as an unfavorable survival marker.

THCA, LUSC, and ESCA are the cancer types where RNU7-38P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	All	0.574	0.937	<.001	108	view →
LUSC	OS	Tertile	III,IV	0.001	0.684	<.001	105	view →
ESCA	OS	Tertile	II,III,IV	0.567	0.758	.006	24	view →
KIRC	DFS	Tertile	IV	0.167	0.605	<.001	18	view →
PAAD	OS	Tertile	All	0.263	0.603	<.001	18	view →
GBM	OS	Tertile	All	0.104	0.415	.024	18	view →
ACC	OS	Tertile	All	0.147	0.685	.018	18	view →
LGG	DFS	Tertile	All	0.584	0.745	.016	15	view →
OV	OS	Tertile	IV	0.200	0.416	.015	12	view →
STAD	DFS	Tertile	All	0.600	0.764	.019	9	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

RNU7-38P–THCA (OS)

Open the THCA breakdown →